medroxyprogesterone acetate has been researched along with Thrombophilia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blondon, M; Heckbert, SR; McKnight, B; Psaty, BM; Rice, KM; Smith, NL; Van Hylckama Vlieg, A; Wiggins, KL | 1 |
| Chiba, K; Hosokawa, M; Kobayashi, K; Mimura, N; Nakamura, Y; Shimada, N | 1 |
| Cicinelli, E; De Mitrio, V; Galantino, P; Giannoccaro, F; Marino, R | 1 |
| Aisaka, K; Kaibara, M; Liang, SG; Okinaga, S; Ooka, F; Watanabe, T | 1 |
4 other study(ies) available for medroxyprogesterone acetate and Thrombophilia
| Article | Year |
|---|---|
Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study.
Topics: Aged; Case-Control Studies; Estrogens, Conjugated (USP); Estrogens, Esterified (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Models, Cardiovascular; Postmenopause; Risk; Smoking; Thrombophilia; Venous Thrombosis; Washington | 2013 |
Metabolism of medroxyprogesterone acetate (MPA) via CYP enzymes in vitro and effect of MPA on bleeding time in female rats in dependence on CYP activity in vivo.
Topics: Animals; Bleeding Time; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Isoenzymes; Male; Medroxyprogesterone Acetate; Microsomes, Liver; Phenobarbital; Proadifen; Rats; Rats, Wistar; Recombinant Proteins; Thrombophilia | 2003 |
Improved sensitivity to activated protein C following postmenopausal hormone replacement therapy.
Topics: Administration, Cutaneous; Adult; Aged; Blood Coagulation; Disease Susceptibility; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Factor V; Factor VIII; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Postmenopause; Protein C; Protein S; Thrombophilia | 1998 |
Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Antithrombin III; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Combined Modality Therapy; Endometrial Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematocrit; Hemostasis; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Peptide Hydrolases; Platelet Count; Risk; Thrombophilia | 2001 |